Roquefort Therapeutics (ROQ)

Sector:

Alternative Investment Instruments

 8.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 9.25
  • 52 Week Low: 5.90
  • Currency: UK Pounds
  • Shares Issued: 129.15m
  • Volume: 68,669
  • Market Cap: £10.98m

ROQ Overview

We established Roquefort Therapeutics plc to acquire businesses focused on early-stage opportunities in the medical biotechnology sector with the aim of generating optimal returns for both the target businesses and our shareholders. The investment strategy of the Company is to provide Shareholders with an attractive total return achieved primarily through capital appreciation. The Directors believe that there are numerous investment opportunities within both private and public businesses in the medical biotech sector in the United Kingdom, Continental Europe and Australia.

Key Personnel

Chief Executive Officer : Trevor Ajanthan (Ajan) Reginald
Chief Scientific Officer: Professor Sir Martin Evans
Executive Chairman: Stephen Paul West
Independent Non-Executive Director: Michael Stein
Non-Executive Dir: Dr Darrin Disley, Simon Sinclair, Jean Duvall

Contact Details

Address: Eccleston Yards, 25 Eccleston Place, London, United Kingdom, SW1W 9NF
Phone: +44 (0)20 3290 9339
Website: http://www.roquefortinvest.com/

Listings

Sector: Alternative Investment Instruments(LSE)
ISIN: GB00BMDQ2T15

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ROQ Market Data

Currency UK Pounds
Share Price 8.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 9.25
52 Week Low 5.90
Volume 68,669
Shares Issued 129.15m
Market Cap £10.98m

ROQ Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.32% below the market average27.32% below the market average27.32% below the market average27.32% below the market average27.32% below the market average
17.86% above the sector average17.86% above the sector average17.86% above the sector average17.86% above the sector average17.86% above the sector average
Price Trend
61.23% above the market average61.23% above the market average61.23% above the market average61.23% above the market average61.23% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income Not Available
Growth Not Available

ROQ Dividends

No dividends found

Trades for 01-Mar-2024

Time Volume / Share Price
17:10 3,000 @ 8.50p
13:53 3,000 @ 8.67p
09:17 62,650 @ 8.00p
08:16 19 @ 9.00p

Top of Page